Wie hoch ist der Preis für Asensus Surgical, Inc. (ASXC)

Preis für Asensus Surgical, Inc. (ASXC) ist $0.3479

Wie hoch ist die Marktkapitalisierung für Asensus Surgical, Inc. (ASXC)

Marktkapitalisierung für Asensus Surgical, Inc. (ASXC) ist $94.92M

Asensus Surgical, Inc. (ASXC) KBV

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.

Jahr	P/B-Verhältnis	ändert
2026 (TTM)	2.60	9.23%
2023	2.38	189.27%
2022	0.82	-44.66%
2021	1.49	105.45%
2020	0.72	54.31%
2019	0.47	-83.10%
2018	2.78	-86.68%
2017	20.87	29.73%
2016	16.08	11.07%
2015	14.48	-20.60%
2014	18.24	180.53%
2013	6.50	-79.34%
2012	31.46	-157.58%
2011	-54.64	-176.16%
2010	71.74	-36.90%
2009	113.69	24.72%
2008	91.16	-42.18%
2007	157.65	15,955.73%
2006	0.98	-93.39%
2005	14.86	160.73%
2004	5.70	33.11%
2003	4.28	41.79%
2002	3.02	-21.40%
2001	3.84	-24.01%
2000	5.06	0.00%

Jahr

P/B-Verhältnis

ändert

2026 (TTM)

2.60

9.23%

2023

2.38

189.27%

2022

0.82

-44.66%

2021

1.49

105.45%

2020

0.72

54.31%

2019

0.47

-83.10%

2018

2.78

-86.68%

2017

20.87

29.73%

2016

16.08

11.07%

2015

14.48

-20.60%

2014

18.24

180.53%

2013

6.50

-79.34%

2012

31.46

-157.58%

2011

-54.64

-176.16%

2010

71.74

-36.90%

2009

113.69

24.72%

2008

91.16

-42.18%

2007

157.65

15,955.73%

2006

0.98

-93.39%

2005

14.86

160.73%

2004

5.70

33.11%

2003

4.28

41.79%

2002

3.02

-21.40%

2001

3.84

-24.01%

2000

5.06

0.00%

Unternehmen	P/B-Verhältnis	P/B-Verhältnis-Differenz	Land
Abbott Laboratories ABT.US	3.7944	45.96%	US
Stryker Corporation SYK.US	5.423	108.60%	US
Medtronic plc MDT.US	2.0146	-22.51%	IE
Boston Scientific Corporation BSX.US	3.072	18.17%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Unternehmen

P/B-Verhältnis

P/B-Verhältnis-Differenz

Land